Diabetes-associated macrovascular complications: cell-based therapy a new tool?
Maddalena Gili1, Alberto Orsello, Sara Gallo
1Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy.
Endocrine
|April 2, 2013
Summary
Stem/progenitor cells show promise for treating diabetes complications, but dysfunction in diabetic patients requires ex vivo manipulation for effective vascular repair. Novel approaches are crucial for this global health challenge.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Endocrinology
Background:
- Diabetes mellitus and its macrovascular complications are a growing global health concern, linked to rising obesity and aging populations.
- Stem/progenitor cells from various tissues are being investigated for therapeutic potential in diabetes complications.
- Existing stem/progenitor cells in diabetic patients (bone marrow, circulating) show dysfunction, necessitating alternative strategies.
Purpose of the Study:
- To review the potential clinical applications of stem/progenitor cells in revascularization and vascular repair for diabetes complications.
- To discuss the challenges associated with using progenitor cells in diabetic patients.
- To explore the role of ex vivo manipulated cells in overcoming stem cell dysfunction in diabetes.
Main Methods:
- Review of preclinical and clinical trial data on stem/progenitor cell applications in diabetes.
- Analysis of stem/progenitor cell sources including bone marrow, peripheral blood, mesenchymal, and adipose tissues.
- Discussion of genetic manipulation techniques for ex vivo cell modification.
Main Results:
- Stem/progenitor cells hold potential for revascularization and vascular repair in diabetes.
- Dysfunction of endogenous stem/progenitor cells in diabetic patients is a significant hurdle.
- Ex vivo manipulation of cells offers a promising strategy to overcome these limitations.
Conclusions:
- Stem/progenitor cell therapy is a promising avenue for managing macrovascular complications of diabetes.
- Addressing stem cell dysfunction through ex vivo manipulation is key to successful clinical translation.
- Further research is needed to optimize cell-based therapies for diabetic vascular disease.
More Related Videos
10:03Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...